| Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling P Guihard, Y Danger, B Brounais, E David, R Brion, J Delecrin, ... Stem cells 30 (4), 762-772, 2012 | 492 | 2012 |
| Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? F Blanchard, C Chipoy Drug discovery today 10 (3), 197-204, 2005 | 294 | 2005 |
| RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis Y Wittrant, S Théoleyre, C Chipoy, M Padrines, F Blanchard, D Heymann, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1704 (2), 49-57, 2004 | 282 | 2004 |
| Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease MA Boutet, G Bart, M Penhoat, J Amiaud, B Brulin, C Charrier, F Morel, ... Clinical & Experimental Immunology 184 (2), 159-173, 2016 | 279 | 2016 |
| The dual role of IL-6-type cytokines on bone remodeling and bone tumors F Blanchard, L Duplomb, M Baud’huin, B Brounais Cytokine & growth factor reviews 20 (1), 19-28, 2009 | 243 | 2009 |
| Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption F Lamoureux, P Richard, Y Wittrant, S Battaglia, P Pilet, V Trichet, ... Cancer research 67 (15), 7308-7318, 2007 | 209 | 2007 |
| Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients M Chemel, B Le Goff, R Brion, C Cozic, M Berreur, J Amiaud, G Bougras, ... Annals of the rheumatic diseases 71 (1), 150-154, 2012 | 175 | 2012 |
| Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma D Heymann, B Ory, F Blanchard, MF Heymann, P Coipeau, C Charrier, ... Bone 37 (1), 74-86, 2005 | 156 | 2005 |
| Oncostatin m, an inflammatory cytokine produced by macrophages, supports intramembranous bone healing in a mouse model of tibia injury P Guihard, MA Boutet, B Brounais-Le Royer, AL Gamblin, J Amiaud, ... The American journal of pathology 185 (3), 765-775, 2015 | 154 | 2015 |
| Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains. F Davodeau, MA Peyrat, A Necker, R Dominici, F Blanchard, C Leget, ... Journal of immunology (Baltimore, Md.: 1950) 158 (12), 5603-5611, 1997 | 154 | 1997 |
| Interleukin-6 inhibits receptor activator of nuclear factor κB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of serine727 … L Duplomb, M Baud’Huin, C Charrier, M Berreur, V Trichet, F Blanchard, ... Endocrinology 149 (7), 3688-3697, 2008 | 144 | 2008 |
| Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor α, and oncostatin M receptor β by distinct mechanisms F Blanchard, Y Wang, E Kinzie, L Duplomb, A Godard, H Baumann Journal of Biological Chemistry 276 (50), 47038-47045, 2001 | 132 | 2001 |
| IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro MA Boutet, A Najm, G Bart, R Brion, S Touchais, V Trichet, P Layrolle, ... Annals of the rheumatic diseases 76 (7), 1304-1312, 2017 | 119 | 2017 |
| Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies F Lamoureux, V Trichet, C Chipoy, F Blanchard, F Gouin, F Redini Expert review of anticancer therapy 7 (2), 169-181, 2007 | 118 | 2007 |
| Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis B Le Goff, F Blanchard, JM Berthelot, D Heymann, Y Maugars Joint Bone Spine 77 (3), 201-205, 2010 | 114 | 2010 |
| Human osteosarcoma cells express functional receptor activator of nuclear factor‐kappa B K Mori, B Le Goff, M Berreur, A Riet, A Moreau, F Blanchard, C Chevalier, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007 | 114 | 2007 |
| Immune modulation by transplanted calcium phosphate biomaterials and human mesenchymal stromal cells in bone regeneration P Humbert, MÁ Brennan, N Davison, P Rosset, V Trichet, F Blanchard, ... Frontiers in immunology 10, 663, 2019 | 111 | 2019 |
| Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process G Moriceau, B Ory, L Mitrofan, C Riganti, F Blanchard, R Brion, C Charrier, ... Cancer Research 70 (24), 10329-10339, 2010 | 109 | 2010 |
| Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation … B Ory, F Blanchard, S Battaglia, F Gouin, F Redini, D Heymann Molecular pharmacology 71 (1), 333-343, 2007 | 109 | 2007 |
| Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor κB ligand … S Theoleyre, SK Tat, P Vusio, F Blanchard, J Gallagher, S Ricard-Blum, ... Biochemical and biophysical research communications 347 (2), 460-467, 2006 | 106 | 2006 |
Marie-Astrid BoutetQueen Mary University of London在 qmul.ac.uk 的电子邮件经过验证
